Shiro Katayama
Director/Miembro de la Junta en Japan BCG Laboratory KK .
Origen de la red de primer grado Shiro Katayama.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Japan BCG Laboratory KK
 Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan.
7
| Private Company | Biotechnology | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Shiro Katayama a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|
Estadísticas
Internacional
Sectorial
Operativa
| Director/Board Member | 7 |
| President | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Shin Kaitani | 1 |
| Manabu Sugano | 1 |
| Naoki Nakata | 1 |
| Takahiko Ikegami | 1 |
| Jun Saito | 1 |
| Hoko Yamashita | 1 |
| Tsuguo Sasaki | 1 |
- Bolsa de valores
- Insiders
- Shiro Katayama
- Conexiones Empresas
